TipRanks
CytomX Therapeutics Inc (DE:6C1)
FRANKFURT:6C1
Germany Market
6C1
CytomX Therapeutics
RESEARCH TOOLSreports

CytomX Therapeutics (6C1) Balance Sheet

6 Followers

CytomX Therapeutics Balance Sheet

CytomX Therapeutics's total assets for Q2 2026 were $381.23M, an increase of 6.09% from the previous quarter. DE:6C1 total liabilities were $79.16M for the fiscal quarter, a 100.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 151.57M$ 120.53M$ 201.79M$ 260.89M$ 339.41M
Total Liabilities
$ 52.56M$ 120.99M$ 249.24M$ 346.64M$ 339.87M
Total Equity Gross Minority
$ 99.01M$ -456.00K$ -47.45M$ -85.75M$ -459.00K
Other Metrics
Currency in USD

CytomX Therapeutics Debt to Assets